Novel KRAS mutation in an unusual tectal low-grade glioma.
作者信息
Wulfovich Sharon, Tucker Suzanne, Levy Michael, Crawford John Ross
机构信息
School of Medicine University of California San Diego Health Sciences, San Diego, California, USA.
Rady Children's Hospital, San Diego, California, USA.
出版信息
BMJ Case Rep. 2021 Apr 1;14(4):e242306. doi: 10.1136/bcr-2021-242306.
Abstract
摘要
相似文献
1
Novel KRAS mutation in an unusual tectal low-grade glioma.罕见的顶盖低级别胶质瘤中的新型KRAS突变
BMJ Case Rep. 2021 Apr 1;14(4):e242306. doi: 10.1136/bcr-2021-242306.
2
Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.顶盖胶质瘤中KRAS G12R以及KRAS和BRAF同时发生改变的发生率很高。
Acta Neuropathol. 2020 Mar;139(3):601-602. doi: 10.1007/s00401-019-02112-x. Epub 2019 Dec 10.
3
Low-grade glioma with novel mutations in and in an adolescent with Down syndrome.一名患有唐氏综合征的青少年的低级别胶质瘤，其[基因名称1]和[基因名称2]存在新的突变。
BMJ Case Rep. 2021 Aug 10;14(8):e245456. doi: 10.1136/bcr-2021-245456.
4
Unusual KRAS missense mutation (p.E63K) in patient with juvenile pilocytic astrocytoma of the tectum.顶盖青少年型毛细胞型星形细胞瘤患者中出现罕见的KRAS错义突变（p.E63K）。
BMJ Case Rep. 2019 Feb 22;12(2):e228128. doi: 10.1136/bcr-2018-228128.
5
Atypical Molecular Features of Pediatric Tectal Glioma: A Single Institutional Series.小儿顶盖胶质瘤的非典型分子特征：单机构系列研究。
J Pediatr Hematol Oncol. 2023 Apr 1;45(3):e410-e414. doi: 10.1097/MPH.0000000000002596. Epub 2022 Nov 22.
6
Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas.致癌性KRAS热点突变在异柠檬酸脱氢酶（IDH）突变型胶质瘤中罕见。
Brain Pathol. 2019 May;29(3):321-324. doi: 10.1111/bpa.12709. Epub 2019 Feb 1.
7
Tectal Low-Grade Glioma with H3 K27M Mutation.顶盖部低级别胶质瘤伴 H3 K27M 突变。
World Neurosurg. 2020 Sep;141:91-100. doi: 10.1016/j.wneu.2020.05.240. Epub 2020 Jun 4.
8
Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis.顶盖胶质瘤作为一种明确的诊断实体：全面的临床、影像学、组织学和分子分析。
Acta Neuropathol Commun. 2018 Sep 25;6(1):101. doi: 10.1186/s40478-018-0602-5.
9
Unusual high-grade and low-grade glioma in an infant with PPP1CB-ALK gene fusion.一名患有PPP1CB-ALK基因融合的婴儿出现罕见的高级别和低级别胶质瘤。
BMJ Case Rep. 2019 Feb 1;12(2):e228248. doi: 10.1136/bcr-2018-228248.
10
Unusual low-grade neuroepithelial tumour with novel PDGFRA mutation.伴有新型血小板衍生生长因子受体A（PDGFRA）突变的罕见低级别神经上皮肿瘤
BMJ Case Rep. 2021 Nov 11;14(11):e247411. doi: 10.1136/bcr-2021-247411.
引用本文的文献
1
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis.顶盖胶质瘤：临床、放射学及病理学特征，以及分子分析的重要性
Brain Tumor Pathol. 2025 Jan;42(1):1-11. doi: 10.1007/s10014-024-00494-9. Epub 2024 Oct 21.
本文引用的文献
1
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.对 1000 例小儿低级别胶质瘤的综合分子与临床分析。
Cancer Cell. 2020 Apr 13;37(4):569-583.e5. doi: 10.1016/j.ccell.2020.03.011.
2
Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.顶盖胶质瘤中KRAS G12R以及KRAS和BRAF同时发生改变的发生率很高。
Acta Neuropathol. 2020 Mar;139(3):601-602. doi: 10.1007/s00401-019-02112-x. Epub 2019 Dec 10.
3
Unusual KRAS missense mutation (p.E63K) in patient with juvenile pilocytic astrocytoma of the tectum.顶盖青少年型毛细胞型星形细胞瘤患者中出现罕见的KRAS错义突变（p.E63K）。
BMJ Case Rep. 2019 Feb 22;12(2):e228128. doi: 10.1136/bcr-2018-228128.
4
Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis.顶盖胶质瘤作为一种明确的诊断实体：全面的临床、影像学、组织学和分子分析。
Acta Neuropathol Commun. 2018 Sep 25;6(1):101. doi: 10.1186/s40478-018-0602-5.
5
Pediatric low-grade gliomas: next biologically driven steps.小儿低度恶性神经胶质瘤：下一步生物学驱动的研究。
Neuro Oncol. 2018 Jan 22;20(2):160-173. doi: 10.1093/neuonc/nox141.
6
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.从10000例患者的前瞻性临床测序中揭示的转移性癌症的突变图谱。
Nat Med. 2017 Jun;23(6):703-713. doi: 10.1038/nm.4333. Epub 2017 May 8.
7
Clinical relevance of KRAS in human cancers.KRAS在人类癌症中的临床相关性。
J Biomed Biotechnol. 2010;2010:150960. doi: 10.1155/2010/150960. Epub 2010 Jun 7.
Zotero 插件